Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXS9CR
|
||||
| Drug Name |
6-{1-[2-(Naphthalen-1-yloxy)-ethyl]-piperidin-4-yloxy}-4H-benzo[1,4]oxazin-3-one
|
||||
| Synonyms |
CHEMBL180445
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C25H26N2O4
|
||||
| Canonical SMILES |
O=C1COc2ccc(OC3CCN(CCOc4cccc5ccccc45)CC3)cc2N1
|
||||
| InChI |
InChI=1S/C25H26N2O4/c28-25-17-30-24-9-8-20(16-22(24)26-25)31-19-10-12-27(13-11-19)14-15-29-23-7-3-5-18-4-1-2-6-21(18)23/h1-9,16,19H,10-15,17H2,(H,26,28)
|
||||
| InChIKey |
HCAWSBHLTGNXKL-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.